NCT02363621 Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME Status COMPLETED Phase PHASE2
NCT02359526 A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients Status COMPLETED Phase PHASE4
NCT02348918 Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT02337972 Conjunctival Flora Patterns After Serial Intravitreal Injections in Diabetic Patients Status UNKNOWN Phase NA
NCT02329132 Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema Status COMPLETED Phase N/A
NCT02325271 Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers Status COMPLETED Phase N/A
NCT02314299 A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration Status COMPLETED Phase PHASE1/PHASE2
NCT02310295 Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema Status COMPLETED Phase NA
NCT02308644 Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study Status COMPLETED Phase PHASE3
NCT02302079 A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE2
NCT02299336 Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial Status COMPLETED Phase PHASE4
NCT02281292 A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema Status WITHDRAWN Phase PHASE1
NCT02262260 Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME Status COMPLETED Phase PHASE3
NCT02259088 A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients Status COMPLETED Phase PHASE3
NCT02245516 Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema Status COMPLETED Phase NA
NCT02232503 Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia Status COMPLETED Phase N/A
NCT02229175 Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema Status WITHDRAWN Phase PHASE2/PHASE3
NCT02227745 Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema Status UNKNOWN Phase N/A
NCT02221453 Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide Status COMPLETED Phase PHASE2